Steward Medical Group D/B/A Permian Premier Health Services and John Lee v. Michelle Armstrong, Individually and as Representative of the Estate of Bobby Fosha, and Peggy Fosha

Court of Appeals of Texas·Decided April 22, 2021·No. 09-20-00243-CV·Published

Opinion

In The

Court of Appeals

Ninth District of Texas at Beaumont

NO. 09-20-00243-CV

STEWARD MEDICAL GROUP D/B/A PERMIAN PREMIER HEALTH SERVICES AND JOHN LEE, Appellants

V.

MICHELLE ARMSTRONG, INDIVIDUALLY AND AS REPRESENTATIVE OF THE ESTATE OF BOBBY FOSHA, AND PEGGY FOSHA, Appellees

On Appeal from the 136th District Court Jefferson County, Texas

Trial Cause No. D-205,748

MEMORANDUM OPINION

The Texas Medical Liability Act requires trial courts to dismiss lawsuits alleging a healthcare liability claim unless the plaintiffs, shortly after they file the suit, serve the defendants with a report that is “an objective good faith effort to comply” with the expert-report requirements in Chapter 74 of the Act. 1 In this

1 Tex. Civ. Prac. & Rem. Code Ann. § 74.351(l).

interlocutory appeal, we must decide whether the trial court abused its discretion by denying the objections the defendants lodged to the plaintiffs’ Chapter 74 reports claiming the plaintiffs’ reports did not represent a good faith effort to provide the reports required by the Act. We conclude that since no abuse of discretion occurred, the trial court’s order denying the defendants’ motion to dismiss should be affirmed.

Background

Michelle Armstrong (as the executor of the Estate of Bobby Fosha) and Peggy Fosha (Bobby Fosha’s widow) sued Dr. John Lee and Steward Medical Group under the Texas Wrongful Death and Survival Act and alleged they negligently caused Bobby Fosha’s death. 2 According to the Plaintiffs’ Original Petition, Bobby died from an adverse side reaction to Celexa, an antidepressant prescribed by Dr. Lee during an office visit on October 23, 2018. In their suit, the plaintiffs alleged that Dr. Lee failed to warn Bobby about the increased risk of suicide they claimed is associated with antidepressants like Celexa. They also alleged that several days after Bobby started taking the medication, Dr. Lee learned from one of Bobby’s family members that Bobby was confused after starting the Celexa. According to the motion

2 See id. § 71.002(b) (under the Texas Wrongful Death Statute, a person is liable “for damages arising from an injury that causes an individual’s death if the injury was caused by the person’s or his agent’s or servant’s wrongful act, neglect, carelessness, unskillfulness, or default”); id. § 71.021(a) (under the Texas Survival Act, a “cause of action for personal injury to the health, reputation, or person of an injured person does not abate because of the death of the injured person”).

to dismiss and the plaintiffs’ response, Celexa comes with warnings, including one stating: “Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior.” In the lawsuit, the plaintiffs alleged Dr. Lee negligently

• failed to prescribe Bobby an appropriate starting dose of Celexa and instead, gave him four times the recommended starting dose under FDA dosing guidelines,

• failed to assess and account for Bobby’s past medical history in prescribing a treatment plan that involved Celexa,

• failed to properly screen Bobby for depression and assess his risk of suicide before prescribing Celexa,

• failed to warn Bobby about the increased risk of suicide associated with Celexa during the office visit and after learning several days later from one of Bobby’s family members that he seemed confused,

• failed to closely monitor Bobby’s Celexa at a reduced dose after being told by a member of Bobby’s family that Bobby was suffering from symptoms Dr. Lee should have recognized as associated with “Celexainduced delirium[,]” and

• failed to discontinue Bobby’s Celexa and instead instructed Bobby’s family to have Bobby take Celexa at a reduced dose after Dr. Lee learned Bobby appeared manic and confused after he started taking Celexa.

The plaintiffs also alleged the above acts and omissions proximately caused Bobby’s death.

Shortly after filing suit, the plaintiffs served Dr. Lee and Steward Medical with two reports, signed by doctors, to meet the requirements of Chapter 74. One report, written by Dr. Michael Dominguez, reflects that he is a board-certified family physician with experience practicing in the field of family medicine, the same area of medicine as Dr. Lee. The other report, signed by Dr. Thomas Kosten, reflects that he is a board-certified psychiatrist and neurologist who has published over 750 papers and books in his field as a psychiatrist, an area that includes the diagnosis and treatment of anxiety disorders, the risk of suicide associated with such disorders, and treating these patients who have these disorders with medications like Celexa.

In Dominguez’s report, he criticized Dr. Lee for failing to obtain a complete medical history after seeing Bobby in his office on October 23, failing to use screening tools that he claims are required to diagnose and document the severity of a patient’s anxiety before prescribing an antidepressant, prescribing Celexa at a higher dose than the one the FDA recommends for patients as old as Bobby, and failing to instruct Bobby’s daughter to take Bobby to an emergency room after learning that Bobby had suffered an adverse reaction after he started the Celexa at the dosage Dr. Lee prescribed. According to Dr. Dominguez, had Dr. Lee not negligently prescribed the medication at too high a dose and had he monitored Bobby based on the standard that applies to starting patients on Celexa, Bobby “more

likely than not and to a reasonable degree of medical probability” would not have shot himself and died.

Dr. Kosten’s report also criticizes Dr. Lee for (1) giving Bobby a prescription for Celexa at a strength higher than the FDA-recommended starting dose; (2) failing to review Bobby’s medical records to assess his risks of taking Celexa given Bobby’s family history, which includes a history showing that Bobby’s father committed suicide; (3) failing to screen Bobby properly to evaluate the severity of Bobby’s depression; (4) failing to warn Bobby about the adverse side-effects of Celexa as related to the medication’s increased risk of suicide; and (5) failing to advise Bobby on October 25 to discontinue the Celexa after Dr. Lee learned from Bobby’s daughter that Bobby appeared to be confused and anxious after he started taking Celexa. As to causation, Dr. Kosten’s report states the above acts and omissions breached the standard of care that applied to treating patients like Bobby. The report concludes the violations he identified in “the standards of care most likely caused [Bobby’s] prescribed overdose of Celexa [and] his suicide . . . within a reasonable degree of medical probability.”

Free access — add to your briefcase to read the full text and ask questions with AI

Steward Medical Group D/B/A Permian Premier Health Services and John Lee v. Michelle Armstrong, Individually and as Representative of the Estate of Bobby Fosha, and Peggy Fosha, (Tex. Ct. App. 2021).

Steward Medical Group D/B/A Permian Premier Health Services and John Lee v. Michelle Armstrong, Individually and as Representative of the Estate of Bobby Fosha, and Peggy Fosha (Steward Medical Group D/B/A Permian Premier Health Services and John Lee v. Michelle Armstrong, Individually and as Representative of the Estate of Bobby Fosha, and Peggy Fosha) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Gardner v. U.S. Imaging, Inc.
274 S.W.3d 669 (Texas Supreme Court, 2008)
American Transitional Care Centers of Texas, Inc. v. Palacios
46 S.W.3d 873 (Texas Supreme Court, 2001)
Bowie Memorial Hospital v. Wright
79 S.W.3d 48 (Texas Supreme Court, 2002)
Christus Health Southeast Texas v. Broussard
306 S.W.3d 934 (Court of Appeals of Texas, 2010)
Downer v. Aquamarine Operators, Inc.
701 S.W.2d 238 (Texas Supreme Court, 1985)
RENAISSANCE HEALTHCARE SYSTEMS, INC. v. Swan
343 S.W.3d 571 (Court of Appeals of Texas, 2011)
Jelinek v. Casas
328 S.W.3d 526 (Texas Supreme Court, 2010)
Van Ness v. ETMC First Physicians
461 S.W.3d 140 (Texas Supreme Court, 2015)
Baty v. Olga Futrell, Crna, & Complete Anesthesia Care, P.C.
543 S.W.3d 689 (Texas Supreme Court, 2018)